Security Snapshot

CLEARONE INC - Common Stock (CLRO) Institutional Ownership

CUSIP: 18506U104

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

$0.42

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / Common Stock
Symbol
CLRO on Nasdaq
Shares outstanding
26,681,675
Price per share
$0.42
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • CLRO - CLEARONE INC - Common Stock is tracked under CUSIP 18506U104.
  • Latest finished 13F holder period is not available.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 16 to 0 between Q1 2025 and Q2 2025.
  • Reported value moved from $795,237 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Security key

18506U104

Latest holder period

n/a

13F holders

13D/G owners

1

CIK / CUSIP context first

CLRO full holder history CLEARONE INC SEC filings CLEARONE INC company facts CLEARONE INC insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Significant Owners of CLEARONE INC - Common Stock (CLRO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAGLEY EDWARD D 50% $7,603,714 13,314,156 BAGLEY EDWARD D 26 Feb 2025

Institutional Holders of CLEARONE INC - Common Stock (CLRO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$795,237 $0.42 0
2025 Q1 1,383,127 $795,237 -$85,188 $0.58 16
2024 Q4 1,465,906 $1,146,923 +$82,583 $0.78 14
2024 Q3 1,373,654 $850,413 +$5,464 $0.62 14
2024 Q2 1,365,125 $887,845 +$119,734 $0.65 18
2024 Q1 1,142,412 $2,090,490 -$152,534 $1.83 14
2023 Q4 1,232,342 $1,332,655 -$124,692 $1.08 14
2023 Q3 1,348,348 $1,024,035 -$316,190 $0.76 13
2023 Q2 1,742,958 $1,443,078 +$578,932 $0.83 17
2023 Q1 1,043,674 $1,575,646 +$261,307 $1.51 10
2022 Q4 870,640 $1,323,123 +$15,783 $1.52 13
2022 Q3 860,018 $464,000 -$31,753 $0.54 7
2022 Q2 918,977 $496,000 -$35,153 $0.54 7
2022 Q1 982,771 $897,000 -$686,056 $0.91 7
2021 Q4 1,609,611 $2,076,000 -$5,120,348 $1.29 10
2021 Q3 3,495,167 $8,215,000 +$5,769,728 $2.35 10
2021 Q2 1,039,948 $2,849,000 -$705,171 $2.74 7
2021 Q1 1,232,142 $4,436,000 +$190,282 $3.60 10
2020 Q4 1,198,593 $2,721,000 -$289,641 $2.27 12
2020 Q3 1,322,243 $3,027,000 +$845,416 $2.29 12
2020 Q2 955,939 $1,912,000 +$95,894 $2.00 10
2020 Q1 898,384 $1,508,000 +$33,471 $1.68 11
2019 Q4 878,584 $1,458,000 +$34,650 $1.66 9
2019 Q3 857,579 $1,570,000 -$3,436 $1.83 10
2019 Q2 859,374 $1,916,000 -$17,882 $2.23 9
2019 Q1 867,795 $1,754,000 +$173,012 $2.02 11
2018 Q4 812,150 $1,013,000 +$229,863 $1.24 13
2018 Q3 603,598 $1,326,000 +$137,887 $2.20 14
2018 Q2 539,872 $2,078,000 +$27,164 $3.85 13
2018 Q1 532,804 $4,234,000 -$258,362 $7.94 12
2017 Q4 564,567 $5,051,000 -$5,525,556 $8.95 13
2017 Q3 1,305,735 $9,727,000 -$1,232,757 $7.45 13
2017 Q2 1,468,950 $13,877,000 -$2,292,910 $9.45 15
2017 Q1 1,701,175 $16,853,000 -$311,192 $9.94 19
2016 Q4 1,751,324 $19,966,000 +$440,072 $11.40 19
2016 Q3 1,709,022 $19,131,000 +$432,622 $11.19 19
2016 Q2 1,670,125 $18,706,000 -$2,820,158 $11.20 19
2016 Q1 1,919,573 $22,265,000 +$1,151,673 $11.58 23
2015 Q4 1,818,817 $23,517,000 +$1,081,152 $12.93 20
2015 Q3 1,737,327 $20,463,000 +$1,209,529 $11.78 22
2015 Q2 1,629,915 $21,033,000 +$3,088,023 $12.90 26
2015 Q1 1,395,056 $14,862,000 +$365,969 $10.66 22
2014 Q4 1,366,787 $13,250,000 +$37,771 $9.69 20
2014 Q3 1,366,272 $11,518,000 -$218,534 $8.43 21
2014 Q2 1,388,650 $13,648,275 -$838,174 $9.83 22
2014 Q1 1,464,797 $15,013,284 +$471,580 $10.25 29
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .